SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000919574-20-000374
Filing Date
2020-01-15
Accepted
2020-01-15 17:25:08
Documents
1
Period of Report
2020-01-09

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 6719
  Complete submission text file 0000919574-20-000374.txt   9660
Mailing Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3
Business Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3 (877) 764-3131
NOVELION THERAPEUTICS INC. (Issuer) CIK: 0000827809 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address MORGAN STANLEY FUND SVCS (CAYMAN) LTD CAYMAN CORPORATE CENTRE, 27 HOSPITAL RD GRAND CAYMAN E9 KY1-9008
Business Address MORGAN STANLEY FUND SVCS (CAYMAN) LTD CAYMAN CORPORATE CENTRE, 27 HOSPITAL RD GRAND CAYMAN E9 KY1-9008 212-808-2460
Broadfin Healthcare Master Fund Ltd (Reporting) CIK: 0001511900 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-17082 | Film No.: 20528930

Mailing Address 300 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022 212-808-2468
Broadfin Capital, LLC (Reporting) CIK: 0001511901 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-17082 | Film No.: 20528929

Mailing Address C/O BROADFIN CAPITAL, LLC 300 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address
KOTLER KEVIN (Reporting) CIK: 0001601692 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-17082 | Film No.: 20528928